About
About China Regenerative Medicine International Limited
China Regenerative Medicine International Limited, together with its subsidiaries, engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China. It operates in two segments, Aesthetic Medical and Beauty Services, and Medical Services. The company offers anti-aging /prevention, functional medicine and solutions, and treatment and diagnosis; hair regenerating medical solutions; and zoom consultation, mental fog therapy, physiotherapy, acnes treatment, and facial and slimming acupuncture services. It also provides skin regeneration, body function refining, Chinese/medical aesthetics, slimming and detoxing, and uterine and circulation services; endoscopy and scar removal services; and medical tests and vaccines. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in February 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Visit company website
5 years, 5 months ago
China Regenerative Medicine International Limited is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
China Regenerative Medicine International Limited's total revenue rose by 389.9% to $62M since the same quarter in the previous year.
Its net income has increased by 28.8% to $-222M since the same quarter in the previous year.
Finally, its free cash flow fell by 1122.6% to $-285M since the same quarter in the previous year.
Based on the above factors, China Regenerative Medicine International Limited gets an overall score of 3/5.